efficacy and toxicity information is presented for naloxone ( as used to reverse opioids ) , physostigmine ( as used for reversal of sedatives ) , and flumazenil ( a new specific benzodiazepine receptor antagonist ) .
C0016293
flumazenil
C1372996
benzodiazepine receptor